Dark

ELVN
Enliven Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jan 9, 2026 3:59:56 PM EST

25.99USD+11.763%(+2.74)5,665,164

26.06Bid 26.11Ask 0.05Spread

Pre-market

Jan 9, 2026 9:27:30 AM EST

23.67USD+1.806%(+0.42)6,030

After-hours

Jan 9, 2026 4:43:30 PM EST

26.06USD+0.289%(+0.07)22,017

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

1.54B

Industry

Biotechnology

Next Earnings

Mar 12, 2026 (61d)

ELVN Stats

Avg. Vol. 10 Day

1,382,600

Avg. Vol. 30 Day

1,021,250

Employees

Market Cap

1,541,249,822

Shares Out.

59,347,317

On/Off Exchange

49%/51%

6 Month Beta

1.52

1 Year Beta

1.16

2 Year Beta

1.49

3 Year Beta

1.39

52 Week Low

13.30

52 Week High

25.59

SMA50

19.31

SMA200

19.64

1 Week

+67.12%

1 Month

+33.25%

3 Month

+21.98%

6 Month

+20.34%

1 Year

+19.46%

2 Year

+90.12%

Profile

enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.

ELVN Stock Summary

Enliven Therapeutics, Inc. Common Stock (NASDAQ:ELVN) stock price today is $25.99, and today's volume is 5,665,164. ELVN is up 11.763% today. The 30 day average volume is 1,021,250. ELVN market cap is 1.54B with 59,347,317 shares outstanding.

.dark-mode .kgzPNf{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .kgzPNf{ color: #333333; background-color: white; border: 2px solid #333333; }ELVNEnliven Therapeutics, Inc. Common Stockstock NASDAQ

ELVN Stock Summary

ELVN
Enliven Therapeutics, Inc. Common Stock
stock NASDAQ